Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account

Table of contents

Details

Guidance for Industry; Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA

FDA-2013-D-1464-0002Other
Document

Details

The document's own metadata, straight from the source system.

Title
Guidance for Industry; Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA
Posted
Dec 4, 2013
Agency
Food and Drug Administration (FDA)
View on regulations.gov ↗